Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

VELOCITY: An Anthrax Vaccine Clinical Study

ClinicalTrials.gov ID: NCT03877926

Public ClinicalTrials.gov record NCT03877926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the lot consistency (using three consecutively manufactured lots), safety, and ability of the AV7909 anthrax vaccine to generate an immune response in healthy adults and compare the response to that induced by the currently licensed vaccine, BioThrax®, (Anthrax Vaccine Adsorbed; AVA) for post-exposure of anthrax disease.

Study identification

NCT ID
NCT03877926
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Emergent BioSolutions
Industry
Enrollment
3,689 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2019
Primary completion
Aug 5, 2020
Completion
Aug 5, 2020
Last update posted
May 5, 2026

2019 – 2020

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216
Optimal Research, LLC Huntsville Alabama 35802
Coastal Clinical Research, an AMR company Mobile Alabama 36608
Central Phoenix Medical Clinic, LLC Phoenix Arizona 85020
Clinical Research Consortium, an AMR company Tempe Arizona 85283
California Research Foundation San Diego California 92103
Optimal Research, LLC San Diego California 92108
Research Centers of America Hollywood Florida 33024
Optimal Research, LLC Melbourne Florida 32934
New Horizon Research Center, Inc Miami Florida 33175
Meridian Clinical Research, LLC Savannah Georgia 31406
Advanced Clinical Research Boise Idaho 83642
Christie Clinic, LLC Champaign Illinois 61820
Optimal Research, LLC Peoria Illinois 61614
The Iowa Clinic, PC West Des Moines Iowa 50266
Heartland Research Associates, LLC Augusta Kansas 67010
Hutchinson Clinic Hutchinson Kansas 67502
Johnson County Clin-Trials, LLC Lenexa Kansas 66219
Heartland Research Associates, LLC Wichita Kansas 67205
Benchmark Research New Orleans Metairie Louisiana 70006
Optimal Research, LLC Rockville Maryland 20850
The Center for Pharmaceutical Research, an AMR company Kansas City Missouri 64114
Meridian Clinical Research, LLC Omaha Nebraska 68134
Clinical Research Center of Nevada LLC Las Vegas Nevada 89104
Rapid Medical Research, Inc. Cleveland Ohio 44122
Aventiv Research Inc. Grove City Ohio 43123
Lynn Institute of Norman Norman Oklahoma 73072
Coastal Carolina Research Center, Inc Mt. Pleasant South Carolina 29464
Spartanburg Medical Research Spartanburg South Carolina 29303
Clinical Research Associates, Inc. Nashville Tennessee 37203
Tekton Research Austin Texas 78745
Benchmark Research Fort Worth Texas 76135
Benchmark Research San Angelo San Angelo Texas 76904
Martin Diagnostic Clinic Tomball Texas 77375
Advanced Clinical Research West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03877926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03877926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →